Antihypertensive regimens that include a mineralocorticoid receptor antagonist carry the highest risk for hyperkalemia. Among the drug combinations that may increase serum potassium in patients with ...
The risk for hyperkalemia was highest with use of steroidal MRAs in combination with other RAASi. In patients with diabetic kidney disease, use of 2 classes of renin-angiotensin-aldosterone system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results